Clinical Trial Update: S100 Protein in Minor/Mild Traumatic Brain Injury

View source ↗

Summary

The trial evaluating S100 protein in minor/mild traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Minor/Mild Traumatic Brain Injury | Status: COMPLETED